# clm_15E21812936B

subject: AbbVie (/record/abbvie.md)  
predicate: board_member  
value: Thomas J. Falk  
valid_from: 2025-05-09  
valid_to: null  
published: 2025-05-13  
recorded: 2026-11-12  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-12  
cite: AsOf. "AbbVie board member: Thomas J. Falk", as of 2025-05-09. Claim clm_15E21812936B, https://asof.is/claim/clm_15E21812936B, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm.  
checked: 2026-11-12 · its source page states the value and the date, as read by an AI model  

> On May 9, 2025, AbbVie Inc. (“AbbVie”) expanded the size of its Board of Directors (the “Board”) from fourteen directors to fifteen directors and appointed Thomas J. Falk as a Class III director.

What https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/1551152/000110465925047402/0001104659-25-047402-index.htm (primary, SEC EDGAR 8-K Item 5.02, published 2025-05-13)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.